SCHEMBL3986304

SCHEMBL3986304

CCn1cc(C)ncc1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
ELANE P08246 1/20 0.35
CREBBP Q92793 1/20 0.35
PLK1 P53350 1/20 0.35
BTK Q06187 1/20 0.34
LMNA P02545 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ABCC4 O15439 1/20 0.33
PKM P14618 1/20 0.33
PTGS1 P23219 1/20 0.33
USP19 O94966 1/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP1A2 P05177 3/20 0.32
HSD17B10 Q99714 2/20 0.32
NFKB1 P19838 1/20 0.32
BLM P54132 1/20 0.32
MAPT P10636 1/20 0.31
BMPR1B O00238 1/20 0.31
BMPR1A P36894 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23789463 0.75 ALDH1A1 (0.34) ALDH1A1
SCHEMBL27369136 0.75 KDM5B (0.37) ALDH1A1CREBBPKDM4ECYP1A2HSD17B10
SCHEMBL24664733 0.72 SORT1 (0.33) ALDH1A1CREBBPBTKMEN1KMT2A
SCHEMBL2629278 0.71
SCHEMBL21484499 0.70 HRH3 (0.38) ALDH1A1CREBBPPLK1LMNAMEN1
SCHEMBL25977054 0.68 ADORA2A (0.35) USP19BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL16589270 0.67 ALDH1A1 (0.31) ALDH1A1LMNA
SCHEMBL25153747 0.67 ADORA2A (0.38) ALDH1A1LMNAPKMKDM4ENFKB1
SCHEMBL11983452 0.65 ALDH1A1 (0.60) ALDH1A1ELANECREBBPBTKLMNA
SCHEMBL10070299 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP disclosed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US disclosed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US disclosed
EP-1756114-A2 HIV INTEGRASE INHIBITORS Merck and Co., Inc. (US) 2007-02-28 EP disclosed
WO-2005110415-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2005-11-24 WO disclosed
WO-2005110414-A2 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287394-A1 Hiv Integrase Inhibitors DHPS, DPYD, TYMP ALDH1A1 913/4885ELANE 2906/4885CREBBP 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.